Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Expert Opin Investig Drugs. 2016 Jun 16;25(8):867–870. doi: 10.1080/13543784.2016.1196185

Figure 1.

Figure 1

Biological plausibility and pleiotropic actions of statin when used to treat/prevent preeclampsia. (HO-1: heme oxygenase-1; sFlt-1: soluble fms-like tyrosine kinase 1; PlGF: placental growth factor; eNOS: endothelial nitric oxide synthase; VEGF: vascular endothelial growth factor; MP: microparticles, EPC: endothelial progenitor cells, hs-CRP: high sensitivity c-reactive protein)